Search Results
You are looking at 1 - 1 of 1 items for
- Author: Robert A Worrell x
- Refine by access: Content accessible to me x
Division of Health Sciences, Murdoch University and Western Australian Biomedical Research Institute, Perth, Western Australia, Australia
Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development,
Genome Technology Branch, National Human Genome Research Institute,
Mathematical and Statistical Computing Laboratory, Center for Information Technology and
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Search for other papers by Susannah Cleary in
Google Scholar
PubMed
Division of Health Sciences, Murdoch University and Western Australian Biomedical Research Institute, Perth, Western Australia, Australia
Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development,
Genome Technology Branch, National Human Genome Research Institute,
Mathematical and Statistical Computing Laboratory, Center for Information Technology and
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Search for other papers by Jacqueline K Phillips in
Google Scholar
PubMed
Division of Health Sciences, Murdoch University and Western Australian Biomedical Research Institute, Perth, Western Australia, Australia
Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development,
Genome Technology Branch, National Human Genome Research Institute,
Mathematical and Statistical Computing Laboratory, Center for Information Technology and
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Search for other papers by Thanh-Truc Huynh in
Google Scholar
PubMed
Division of Health Sciences, Murdoch University and Western Australian Biomedical Research Institute, Perth, Western Australia, Australia
Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development,
Genome Technology Branch, National Human Genome Research Institute,
Mathematical and Statistical Computing Laboratory, Center for Information Technology and
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Division of Health Sciences, Murdoch University and Western Australian Biomedical Research Institute, Perth, Western Australia, Australia
Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development,
Genome Technology Branch, National Human Genome Research Institute,
Mathematical and Statistical Computing Laboratory, Center for Information Technology and
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Search for other papers by Abdel G Elkahloun in
Google Scholar
PubMed
Division of Health Sciences, Murdoch University and Western Australian Biomedical Research Institute, Perth, Western Australia, Australia
Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development,
Genome Technology Branch, National Human Genome Research Institute,
Mathematical and Statistical Computing Laboratory, Center for Information Technology and
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Search for other papers by Jennifer Barb in
Google Scholar
PubMed
Division of Health Sciences, Murdoch University and Western Australian Biomedical Research Institute, Perth, Western Australia, Australia
Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development,
Genome Technology Branch, National Human Genome Research Institute,
Mathematical and Statistical Computing Laboratory, Center for Information Technology and
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Search for other papers by Robert A Worrell in
Google Scholar
PubMed
Division of Health Sciences, Murdoch University and Western Australian Biomedical Research Institute, Perth, Western Australia, Australia
Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development,
Genome Technology Branch, National Human Genome Research Institute,
Mathematical and Statistical Computing Laboratory, Center for Information Technology and
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Search for other papers by David S Goldstein in
Google Scholar
PubMed
Division of Health Sciences, Murdoch University and Western Australian Biomedical Research Institute, Perth, Western Australia, Australia
Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development,
Genome Technology Branch, National Human Genome Research Institute,
Mathematical and Statistical Computing Laboratory, Center for Information Technology and
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Search for other papers by Graeme Eisenhofer in
Google Scholar
PubMed
Phaeochromocytomas are rare neuroendocrine tumours that produce catecholamines and numerous secretory proteins and peptides, including neuropeptide Y (NPY), a vasoactive peptide with influences on blood pressure. The production of catecholamines and NPY by phaeochromocytomas is highly variable. This study examined influences of hereditary factors and differences in catecholamine production on tumour expression of NPY, as assessed by quantitative PCR, enzyme immunoassay and immunohistochemistry. Phaeochromocytomas included hereditary adrenaline-producing tumours (adrenergic phenotype) in multiple endocrine neoplasia type 2 (MEN 2), predominantly noradrenaline-producing tumours (noradrenergic phenotype) in von Hippel–Lindau (VHL) syndrome, and other adrenergic and noradrenergic tumours where there was no clear hereditary syndrome. NPY levels in phaeochromocytomas from VHL patients were lower (P<0.0001) than in those from MEN 2 patients for both mRNA (84-fold difference) and the peptide (99-fold difference). These findings were supported by immunohistochemistry. NPY levels were also lower in VHL tumours than in those where there was no hereditary syndrome. Relative absence of expression of NPY in phaeochromocytomas from VHL patients when compared with other groups appears to be largely independent of differences in catecholamine production and is consistent with a unique phenotype in VHL syndrome.